Searched for
CLINICAL TRIALS IN INDIA
‘India’s biotech ecosystem holds tremendous promise’: Eli Lilly CEOEli Lilly has experienced significant growth, reaching a market capitalization over $1 trillion. The company aims to maintain its leadershi...- Ashwagandha’s 24-week safety test brings reassuring findings: ReportA clinical trial involving 1,200 adults evaluated the safety of standardised ashwagandha root extract. Participants took either ashwagandha...
- Rs 78,400 vs Rs 7,750 medicine: Novartis, Eli Lilly oppose bid to cut breast cancer drug prices in IndiaNovartis and Eli Lilly have opposed a Kerala High Court petition seeking government intervention to make two breast cancer drugs cheaper, d...
- Lord’s Mark advances AI breast cancer screening towards clinical trialsIn a groundbreaking collaboration with C-MET, Lord's Mark Industries Limited is making strides in breast cancer screening technology. Utili...
- Bharat Biotech is 'back in action' after Covid reset: Krishna Ella on TB vaccine, Nipah-Ebola shots, gene therapy, IPO plans & what’s nextBharat Biotech is “back in action” after a two-year post-Covid reset, founder Krishna Ella says, with the company expanding beyond vaccines...
- Ichor Biologics seeks $80-100 million PE funding for minority stake saleIchor Biologics is seeking eighty to one hundred million dollars from private equity investors. The Hyderabad-based company operates in the...
- Wegovy maker Novo Nordisk faces investor pressure to find growth beyond weight-loss drugsFacing increased scrutiny, Novo Nordisk must clarify its future strategy outside of its leading weight-loss drug. Investors are advocating ...
- Health ministry issues advisory against unregulated stem cell therapies, restricts autism treatment to approved clinical trialsThe Union health ministry issued an advisory against unregulated stem cell therapies. Therapeutic use of stem cells for autism is restricte...
- Health Ministry issues advisory clamping down on unregulated use of stem cell therapiesThe Union Health Ministry has tightened oversight of stem cell therapies, warning against their unregulated use and making clear that they ...
- Supreme Court upholds Himachal HC ruling on drug regulator powers, impacting CDSCO enforcementThe Supreme Court dismissed the Union government's challenge to a High Court judgment. This ruling clarified jurisdiction over drug regulat...
- Agonisingly slow clinical trial is stopping Indian pharma become global innovator from supplierIndia's regulatory hurdles slow down early-stage drug trials significantly. This complexity causes Indian companies to conduct crucial firs...
- Centre proposes easier norms for faster drug rolloutIndia's government plans to streamline drug approval processes for domestic use. Applicants can now start studies after intimating the drug...
- Manipal Hospitals scouts for acquisitions in Andhra, Keralam, Delhi-NCR; bets on AI-led healthcareManipal Health Enterprises plans significant expansion across several Indian states. The company is adopting a digital-physical healthcare ...
- AI, trauma, bionics: India’s top institutes join forces to develop medical care for soldiersTop Indian health institutions are partnering with the Armed Forces Medical Services. These collaborations focus on developing advanced med...
- Tata Capital Healthcare Fund to exit Linux Laboratories as ChrysCapital buys 20-25% stakePrivate equity firm ChrysCapital is set to acquire a significant stake in Linux Laboratories. This deal will see existing investor Tata Cap...
- Pharma sector must attract more investment in clinical trials, R&D: Piyush GoyalPiyush Goyal emphasized the importance of enhancing India's pharmaceutical industry to draw in more investments. He urged for the creation ...
- DRL, Emcure get approval to make breakthrough HIV drugIndia's drug regulator has cleared the path for local lenacapavir manufacturing. Two Indian pharmaceutical companies received waivers for l...
- The long and winding R&D: While India tracks where publicly funded research money goes, it should track what it createsIndia's research funding system suffers a staggering ₹3,000 crore in losses each year due to overlapping grants. Implementing a unified tra...
- State can't take life arbitrarily or without dignity: Supreme CourtThe Supreme Court ruled that state execution powers are not arbitrary. The method of execution must uphold human dignity and minimize suffe...
- Regulator mandates full review of globally unapproved drugsIndia’s drug regulator has clarified that new drugs not approved anywhere globally must undergo the full domestic regulatory process, even ...
Load More
